Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Hose

Showing results (41-50 of 189) with videos related to

Pageof 19
Sort By:
American Journal of Hematology|August 11, 2016
Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myelomaMaximilian Merz, Thomas Hielscher, Anja Seckinger, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 25, 2022
Patient and Caregiver Experience Decision Factors in Treatment Decision Making: Results of a Systematic Literature Review of Multiple Myeloma Decision AidsMimi Choon-Quinones, Dirk Hose, Zoltán Kaló, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Input of DNA microarrays to identify novel mechanisms in multiple myeloma biology and therapeutic applicationsKarène Mahtouk, Dirk Hose, John De Vos, et al.
Oncotarget|February 12, 2015
Drug metabolism and clearance system in tumor cells of patients with multiple myelomaWafa Hassen, Alboukadel Kassambara, Thierry Reme, et al.
British Journal of Haematology|February 3, 2009
Gene expression of anti- and pro-apoptotic proteins in malignant and normal plasma cellsMichel Jourdan, Thierry Reme, Hartmut Goldschmidt, et al.
Journal of Medical Economics|November 18, 2022
Beyond medicines' barriers: exploring the true cost of multiple myelomaMimi Choon-Quinones, Tamás Zelei, Mike Barnett, et al.
Blood|October 23, 2009
An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterizationMichel Jourdan, Anouk Caraux, John De Vos, et al.
Haematologica|June 13, 2012
Changes in magnetic resonance imaging before and after autologous stem cell transplantation correlate with response and survival in multiple myelomaJens Hillengass, Sofia Ayyaz, Kerstin Kilk, et al.
Cell Cycle (Georgetown, Tex.)|August 23, 2013
DNA repair pathways in human multiple myeloma: role in oncogenesis and potential targets for treatmentClaire Gourzones-Dmitriev, Alboukadel Kassambara, Surinder Sahota, et al.
Experimental Hematology|February 15, 2011
Gene expression profile of ADAMs and ADAMTSs metalloproteinases in normal and malignant plasma cells and in the bone marrow environmentCaroline Bret, Dirk Hose, Thierry Reme, et al.
Pageof 19

Showing results (41-50 of 189) with videos related to

Sort By:
Pageof 19
American Journal of Hematology|August 11, 2016
Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myelomaMaximilian Merz, Thomas Hielscher, Anja Seckinger, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 25, 2022
Patient and Caregiver Experience Decision Factors in Treatment Decision Making: Results of a Systematic Literature Review of Multiple Myeloma Decision AidsMimi Choon-Quinones, Dirk Hose, Zoltán Kaló, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Input of DNA microarrays to identify novel mechanisms in multiple myeloma biology and therapeutic applicationsKarène Mahtouk, Dirk Hose, John De Vos, et al.
Oncotarget|February 12, 2015
Drug metabolism and clearance system in tumor cells of patients with multiple myelomaWafa Hassen, Alboukadel Kassambara, Thierry Reme, et al.
British Journal of Haematology|February 3, 2009
Gene expression of anti- and pro-apoptotic proteins in malignant and normal plasma cellsMichel Jourdan, Thierry Reme, Hartmut Goldschmidt, et al.
Journal of Medical Economics|November 18, 2022
Beyond medicines' barriers: exploring the true cost of multiple myelomaMimi Choon-Quinones, Tamás Zelei, Mike Barnett, et al.
Blood|October 23, 2009
An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterizationMichel Jourdan, Anouk Caraux, John De Vos, et al.
Haematologica|June 13, 2012
Changes in magnetic resonance imaging before and after autologous stem cell transplantation correlate with response and survival in multiple myelomaJens Hillengass, Sofia Ayyaz, Kerstin Kilk, et al.
Cell Cycle (Georgetown, Tex.)|August 23, 2013
DNA repair pathways in human multiple myeloma: role in oncogenesis and potential targets for treatmentClaire Gourzones-Dmitriev, Alboukadel Kassambara, Surinder Sahota, et al.
Experimental Hematology|February 15, 2011
Gene expression profile of ADAMs and ADAMTSs metalloproteinases in normal and malignant plasma cells and in the bone marrow environmentCaroline Bret, Dirk Hose, Thierry Reme, et al.
Pageof 19